Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Information technology (IT) systems should be able to capture data useful to management to better understand the company’s risk profile and risk management. This means not granting exceptions ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland.

Investors with a lot of money to spend have taken a bullish stance on DexCom DXCM ... company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for ...

Insulet Corporation (NASDAQ:PODD) showcases a strong financial performance with a ROIC of 16.28% and a WACC of 10.24%, indicating efficient capital use. Compared to peers like DexCom and Tandem ...